Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Gangat N, Tefferi A.
Am J Hematol. 2021 Mar 1;96(3):354-366. doi: 10.1002/ajh.26067. Epub 2020 Dec 28.
PMID:33296529
First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin.
Leković D, Gotić M, Ljubić A.
Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):210-3. doi: 10.2298/sarh1504210l.
PMID:26012134
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Gangat N, Singh A, Ilyas R, Loscocco GG, Elliott M, Begna K, Pardanani A, Tefferi A.
Am J Hematol. 2024 Oct;99(10):1862-1869. doi: 10.1002/ajh.27416. Epub 2024 Jun 12.
PMID:38867546
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, Shehata N.
JAMA Netw Open. 2019 Oct 2;2(10):e1912666. doi: 10.1001/jamanetworkopen.2019.12666.
PMID:31584685
Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.
Bohîlţea RE, Cîrstoiu MM, Ionescu CA, Niculescu-Mizil E, Vlădăreanu AM, Voican I, Dimitriu M, Turcan N.
Medicine (Baltimore). 2017 Nov;96(46):e8735. doi: 10.1097/MD.0000000000008735.
PMID:29145319
Essential thrombocythemia.
Schafer AI.
Prog Hemost Thromb. 1991;10:69-96.
PMID:2008534
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms.
Bose P, Xiao Z, Hasselbalch HC, Prchal JT, Duan M, Yacoub A, Rampal R, Kiladjian JJ, Hobbs GS, Tashi T, Shimoda K, Kirito K, Gill H, Hou HA, Lee SE, Huang J, Li B, Qin A, Yu LH, Mascarenhas JO, Mesa RA.